Figures 7G-I illustrate the distribution of risk levels, survival status, and survival time of BC patients within these two groups. Additionally, the relative expression levels of four BC-associated genes were presented for each patient, where ANO6 and CEMIP were identified as high-risk genes, and SLC1A1 and CLIC6 as low-risk genes. We evaluated the model’s prognostic accuracy using a standardized test set and a risk score concentration formula for each patient. Figures 8A, B display the model’s nomogram, which demonstrates the model’s precision in prognostication. This evidence concerns the gene CEMIP and breast cancer.